glp-1 release Glucagon-like peptide-1 GLP-1 for Weight Loss and

Highly Significant Long-term Health Benefits for All Reduction in Major Cardiac Events: Studies have shown a significant decrease in major cardiac events, including a 27% reduction in fatal heart attacks

Nonadherence was determined based on the date of treatment discontinuation with GLP1 RA or metformin, day 90 (index) if no further prescription than the initial was redeemed

Jacobsen LV, Hindsberger C, Robson R, Zdravkovic M

Metabolism Open, 10 , 100093

Oral semaglutide (Rybelsus) exists but is lower efficacy and approved only for type 2 diabetes

Taking these medications finally changed not only my appetite, but the entire way I think about food, hunger, and self-care